4.6 Article

Vessels that encapsulate tumor clusters (VETC) pattern predicts the efficacy of adjuvant TACE in hepatocellular carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Regulatory mechanism of HIF-1α and its role in liver diseases: a narrative review

Qingfei Chu et al.

Summary: Liver disease is a global public health issue with limited treatment options. HIF-1 alpha plays a crucial role in various liver diseases, indicating the importance of targeting HIF-1 alpha for potential liver disease treatment.

ANNALS OF TRANSLATIONAL MEDICINE (2022)

Article Gastroenterology & Hepatology

MiR-125b Loss Activated HIF1α/pAKT Loop, Leading to Transarterial Chemoembolization Resistance in Hepatocellular Carcinoma

Xiyang Wei et al.

Summary: miR-125b loss activates the HIF1 alpha/pAKT loop, contributing to HCC resistance to TACE. Key nodes in this axis hold the potential in assisting patients with HCC to choose TACE therapy.

HEPATOLOGY (2021)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

COCH predicts survival and adjuvant TACE response in patients with HCC

Chen Wang et al.

Summary: This study found that the expression level of COCH is related to the prognosis and recurrence of HCC patients, with lower expression levels associated with reduced early recurrence rates when treated with TACE. However, high COCH expression patients did not see a difference in recurrence rates with or without adjuvant TACE.

ONCOLOGY LETTERS (2021)

Review Medicine, General & Internal

Hepatocellular carcinoma

Alejandro Forner et al.

LANCET (2018)

Article Medical Laboratory Technology

The diagnosis and treatment of hepatocellular carcinoma

Justin Hartke et al.

SEMINARS IN DIAGNOSTIC PATHOLOGY (2017)

Article Cell Biology

Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma

Jia-hong Wang et al.

CELL DEATH & DISEASE (2017)

Review Oncology

Hypoxia inducible factors in hepatocellular carcinoma

Chu Chen et al.

ONCOTARGET (2017)

Review Oncology

Surgical Treatment for Hepatocellular Carcinoma

Tadatoshi Takayama

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2011)

Review Gastroenterology & Hepatology

Risk of HCC: Genetic heterogeneity and complex genetics

Tommaso A. Dragani

JOURNAL OF HEPATOLOGY (2010)

Article Oncology

Sinusoidal tumor angiogenesis is a key component in hepatocellular carcinoma metastasis

Takashi Sugino et al.

CLINICAL & EXPERIMENTAL METASTASIS (2008)

Review Gastroenterology & Hepatology

Molecular Mechanisms of Hepatocellular Carcinoma

Rajagopal N. Aravalli et al.

HEPATOLOGY (2008)

Article Gastroenterology & Hepatology

Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma

P Mathurin et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)